Monograph Details
|
|
Urogenital System
> Miscellaneous urogenital disorders
|
|
K-PHOS ORIGINAL |
| Manufacturer |
|
Beach Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Urinary acidifier. |
| Generic Name |
|
Potassium acid phosphate 500mg; equiv. to potassium 3.67mEq; scored tabs. |
| Also |
• K-PHOS M.F.
• K-PHOS #2
|
| Indications |
|
Urinary acidification. |
| Children |
|
Not recommended. |
| Adults |
|
2 tabs dissolved in 6–8oz water 4 times a day with meals and at bedtime. |
| Contraindications |
|
Renal or adrenal insufficiency. Severe hepatic disease. Infected phosphate stones. Hyperphosphatemia. Hyperkalemia (Original). |
| Precautions |
|
Electrolyte restrictions. Cardiac disease. Hypertension. Edema. Monitor serum electrolytes and for GI obstruction. Discontinue if laxation persists after dosage reduction. Hypoparathyroidism. Osteomalacia. Pancreatitis. Dehydration. Toxemia of pregnancy. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Antagonized by antacids. Hyperkalemia with ACE inhibitors, triamterene, spironolactone, amiloride, potassium supplements. Toxicity with digitalis. Hypernatremia with methyldopa, guanethidine, other antihypertensives, corticotropins, mineralocorticoids. |
| Adverse Reactions |
|
Small bowel lesions, laxation, headache, dizziness, hyperacidity, nausea, weakness, confusion, paresthesias, seizures, arrhythmias, shortness of breath, edema. |
| How Supplied |
|
Tabs—100 |
|
|
|
|